Literature DB >> 2460352

Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma.

K Buchali1, H J Correns, M Schuerer, D Schnorr, H Lips, K Sydow.   

Abstract

Forty-nine patients were treated with either 3 x 75 MBq 89Sr or saline as placebo. Analysis of results 1 to 3 years after therapy revealed the ineffectiveness of 89Sr to relieve pain from metastases. Unexpectedly, a higher survival rate was found after Sr application (46% vs 4% after 2 years). Covariate analysis underlines the effect of 89Sr therapy on life expectation.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2460352     DOI： 10.1007/bf00254382

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  8 in total

1.  [Yttrium-90-therapy of bone metastases].

Authors:  J Kutzner; W Grimm; K H Brod; A Roesler
Journal:  Dtsch Med Wochenschr       Date:  1982-09-10       Impact factor: 0.628

2.  [Internal radiotherapy using strontium-89 in metastases-induced pain].

Authors:  J Kutzner; W Grimm; K Hahn
Journal:  MMW Munch Med Wochenschr       Date:  1977-09-30

3.  Results of 89strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: a preliminary report.

Authors:  N Firusian; P Mellin; C G Schmidt
Journal:  J Urol       Date:  1976-12       Impact factor: 7.450

4.  Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate.

Authors:  G M Blake; M A Zivanovic; A J McEwan; D M Ackery
Journal:  Eur J Nucl Med       Date:  1986

5.  89Strontium therapy of bone metastases of carcinoma of the prostatic gland.

Authors:  H J Correns; M Mebel; K Buchali; D Schnorr; C Seidel; E Mitterlechner
Journal:  Eur J Nucl Med       Date:  1979-02-01

6.  Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma.

Authors:  R M Levenson; B J Sauerbrunn; H R Bates; R D Newman; J L Eddy; D C Ihde
Journal:  Radiology       Date:  1983-02       Impact factor: 11.105

7.  Strontium-89 therapy for the pain of osseous metastases.

Authors:  E B Silberstein; C Williams
Journal:  J Nucl Med       Date:  1985-04       Impact factor: 10.057

8.  Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer.

Authors:  H Langhammer; R Sintermann; G Hör; H W Pabst
Journal:  Nuklearmedizin       Date:  1978-07       Impact factor: 1.379
  8 in total
  23 in total

1.  Prostate cancer: 10. Palliative care.

Authors:  N A Iscoe; E Bruera; R C Choo
Journal:  CMAJ       Date:  1999-02-09       Impact factor: 8.262

Review 2.  WITHDRAWN: Radiotherapy for the palliation of painful bone metastases.

Authors:  Henry J McQuay; Sally L Collins; Dawn Carroll; R Andrew Moore; Sheena Derry
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

Review 3.  Strategies for management of prostate cancer-related bone pain.

Authors:  R C Pelger; V Soerdjbalie-Maikoe; N A Hamdy
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  Treatment of Bone Metastasis with Bone-Targeting Radiopharmaceuticals.

Authors:  Joon Young Choi
Journal:  Nucl Med Mol Imaging       Date:  2018-01-12

5.  Comparison of non-invasive approaches to red marrow dosimetry for radiolabelled monoclonal antibodies.

Authors:  M A Plaizier; J C Roos; G J Teule; E B van Dieren; W den Hollander; H J Haisma; R L DeJager; A van Lingen
Journal:  Eur J Nucl Med       Date:  1994-03

Review 6.  Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data.

Authors:  Charles J Ryan; Philip J Saylor; Jason J Everly; Oliver Sartor
Journal:  Oncologist       Date:  2014-09-17

7.  Emerging Therapeutic for the Treatment of Skeletal-related Events Associated With Metastatic Castrate-resistant Prostate Cancer.

Authors:  Paul R Sieber
Journal:  Rev Urol       Date:  2014

Review 8.  Radioisotopic treatment of bone pain from metastatic prostate cancer.

Authors:  Oliver Sartor
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

Review 9.  Radiotherapeutic approaches to metastatic disease.

Authors:  Edward Chow; Jackson Wu; Andrew Loblaw; Carlos A Perez
Journal:  World J Urol       Date:  2003-08-09       Impact factor: 4.226

10.  Concurrent dendritic cell vaccine and strontium-89 radiation therapy in the management of multiple bone metastases.

Authors:  J Liu; J Li; Y Fan; K Chang; X Yang; W Zhu; X Wu; Yan Pang
Journal:  Ir J Med Sci       Date:  2014-05-30       Impact factor: 1.568
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.